David Katz

|RSS

David Katz is the president and chief investment officer of Matrix Asset Advisors, which he co-founded in 1986. Prior to co-founding Matrix, he worked at Management Asset Corp. in the research and portfolio management areas. At Matrix, Katz chairs the Investment Policy Committee.Expand

Katz is a CFA charterholder who appears frequently as a guest on CNBC, Bloomberg Television and Radio and WCBS-AM in New York. He graduated summa cum laude from Union College with a Bachelor of Arts degree in economics. He received a Master of Business Administration degree, with a concentration in finance, from New York University Graduate School of Business in 1987, graduating with distinction. His numerous works on value investing earned him various awards and distinctions at the undergraduate and graduate levels.Collapse

By

David Katz

 | May 22, 2015 | 7:00 AM EDT

Their volatility could be more suitable for fast-money speculators.

By

David Katz

 | May 21, 2015 | 11:39 AM EDT
We recommended Emerson in early February at $56.90. We like it on a longer term basis and investors are paid over a 3% dividend yield while they wait...
By

David Katz

 | May 21, 2015 | 9:17 AM EDT
QCOM announced that it has started its Accelerated Share Repurchase Program this morning by entering into pacts with Morgan Stanley and Goldman Sachs...
By

David Katz

 | May 21, 2015 | 9:15 AM EDT
This morning CVS announced the purchase of Omnicare for $98 per share in cash. The deal seems to make strategic sense and after modest dilution in...
By

David Katz

 | May 20, 2015 | 8:00 AM EDT

It's time to take some profits on the company's success.

By

David Katz

 | May 15, 2015 | 7:00 AM EDT

The tech company needs to find a buyer. Now.

By

David Katz

 | May 13, 2015 | 9:36 AM EDT
It appears that Nelson Peltz has lost in his bid to gain seats on the DuPont Board. We believe Peltz's presence and game plan made a lot of sense...
By

David Katz

 | May 13, 2015 | 8:00 AM EDT

Internal or external activism should benefit these stocks.

By

David Katz

 | May 8, 2015 | 7:00 AM EDT

Turnaround plan and new CEO show promise.

By

David Katz

 | May 6, 2015 | 7:00 AM EDT

Investors should step up even before Biomet acquisition OK'd.

There is $1.25 billion to sell market on close as of 347PM.

Goldman Sachs say Yellen is "balanced." Their view is that the Fed Chair downplayed weak 1...
There was nothing new at all out of Yellen's speech today. She expects rates to rise this ...

BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.